amphetamine has been researched along with 3,4-methylenedioxyamphetamine in 71 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (23.94) | 18.7374 |
| 1990's | 23 (32.39) | 18.2507 |
| 2000's | 17 (23.94) | 29.6817 |
| 2010's | 9 (12.68) | 24.3611 |
| 2020's | 5 (7.04) | 2.80 |
| Authors | Studies |
|---|---|
| Bartyzel, P; Glennon, RA; Leonhardt, S; Raghupathi, R; Teitler, M | 1 |
| Anderson, GM; Castagnoli, N; Domelsmith, LN; Eaton, TA; Glennon, RA; Houk, KN; Kollman, PA; Shulgin, AT | 1 |
| Anderson, GM; Glennon, RA; Liebowitz, SM | 1 |
| Glennon, RA | 1 |
| Canfield, DV; Epstein, RL; Lorimer, P | 1 |
| DiStefano, V; Ling, LL; Marquardt, GM | 1 |
| Callaway, CW; Geyer, MA | 2 |
| Huang, XM; Johnson, MP; Nichols, DE | 1 |
| Baugh, D; Gan, BK; Liu, RH; Walia, AS | 1 |
| Culp, S; De Souza, EB; Zaczek, R | 1 |
| Evans, SM; Johanson, CE; Zacny, JP | 1 |
| Callaway, CW; Geyer, MA; Wing, LL | 1 |
| Abbate, GM; Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Gold, LH; Hubner, CB; Koob, GF | 1 |
| Gold, LH; Koob, GF | 1 |
| Glennon, RA; Misenheimer, BR | 1 |
| Brady, JF; Cho, AK; Di Stefano, EW | 1 |
| Johanson, CE; Kamien, JB; Schuster, CR; Woolverton, WL | 1 |
| Evans, SM; Johanson, CE | 1 |
| Nichols, DE; Steele, TD; Yim, GK | 1 |
| Fitzgerald, RL; Poklis, A; Ramos, JM | 1 |
| Nichols, DE; Oberlender, R | 1 |
| Frank, RS | 1 |
| Glennon, RA; Young, R | 2 |
| Cirimele, V; Kintz, P; Mangin, P; Tracqui, A | 1 |
| Dasgupta, A; Thompson, WC | 1 |
| Marona-Lewicka, D; Nichols, DE | 1 |
| Castagna, F; Ferrara, SD; Frison, G; Giorgetti, R; Tedeschi, L | 1 |
| Fitzgerald, JL; Reid, JJ | 1 |
| Fitzgerald, RL; Hall, KV; Poklis, A; Saady, JJ | 1 |
| Barrett, PJ; Taylor, GT | 1 |
| Cadier, MA; Clarke, JA | 1 |
| Huang, X; Nichols, DE | 1 |
| Cox, DE; Williams, KR | 1 |
| Marona-Lewicka, D; Nichols, DE; Rhee, GS; Sprague, JE | 1 |
| Kauert, G; Röhrich, J | 2 |
| Kaa, E; Simonsen, KW | 1 |
| Mirken, B | 1 |
| Brehm, G; Sägmüller, B; Schneider, S; Schwarze, B | 1 |
| Dams, R; De Leenheer, AP; De Letter, EA; Lambert, WE; Mortier, KA; Van Calenbergh, S | 1 |
| Barnett, DA; Ells, B; Guevremont, R; McCooeye, MA; Mester, Z; Purves, RW | 1 |
| Kovar, KA; Mayerhofer, A; Meyer, A; Schmidt, WJ | 1 |
| Cooper, DP; De Boeck, G; De Bruijn, EA; Maes, RA; Morris, M; Samyn, N; Wood, M | 1 |
| Huang, Z; Zhang, S | 1 |
| Hugel, J; Kalasinsky, KS; Kish, SJ | 1 |
| De Boeck, G; Laloup, M; Maes, V; Ramaekers, J; Samyn, N; Tilman, G; Wallemacq, P | 1 |
| Johansen, SS; Olsen, KH; Rasmussen, LB | 1 |
| Martins, LF; Ramaekers, JG; Samyn, N; Wennig, R; Yegles, M | 1 |
| Andersson, M; Beck, O; Gustavsson, E; Stephanson, N | 1 |
| Chiang, JS; Huang, SD | 1 |
| Jones, AW | 1 |
| Cheong, JC; In, MK; Kim, JY; Kim, MK; Lee, JI | 1 |
| Bafile, E; Compagnone, D; Curini, R; D'Ascenzo, G; Romolo, FS; Sergi, M | 1 |
| Maurer, HH; Meyer, MR; Peters, FT | 1 |
| In, MK; Kim, JY; Lee, JI; Shin, SH | 1 |
| Blacik, LJ; Kazarian, CM; Ntamack, AG; Romberg, RW; Snyder, JJ; Welsh, ER | 1 |
| Baylor, MR; Bynum, ND; Lewallen, CM; Mitchell, JM; Ropero-Miller, JD; Stout, PR | 1 |
| Hondebrink, L; Meijer, M; Meulenbelt, J; Rietjens, SJ; Westerink, RH | 1 |
| Hara, K; Hasegawa, C; Kumazawa, T; Lee, XP; Sato, K; Seno, H; Suzuki, O; Uchigasaki, S | 1 |
| Boldizsár, I; Fodor, B; Molnár, B; Molnár-Perl, I | 1 |
| Bagnall, J; Evans, SE; Kasprzyk-Hordern, B | 1 |
| Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
| Almeida, D; Castro, AL; Franco, JM; Sousa, L; Tarelho, S; Teixeira, HM | 1 |
| Lee, WM; Li, CK; Wong, GF | 1 |
| Ducret, P; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Trachsel, D | 1 |
| Cruz, SL; Paz-Ramos, MI; Violante-Soria, V | 1 |
| Cui, SF; Huang, X; Wan, JW; Yang, HL | 1 |
| Halsted, DL; Pascale, PJ; Streit, F | 1 |
1 review(s) available for amphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
1 trial(s) available for amphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; ROC Curve; Saliva; Sensitivity and Specificity; Substance Abuse Detection | 2005 |
69 other study(ies) available for amphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Topics: Animals; Binding Sites; Binding, Competitive; Ergolines; Ketanserin; Male; Molecular Structure; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Structure-Activity Relationship; Tritium | 1992 |
Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues.
Topics: Amphetamines; Animals; Chemical Phenomena; Chemistry, Physical; Humans; Psychotropic Drugs; Rabbits; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1981 |
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Serotonin; Stomach; Structure-Activity Relationship | 1980 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Gas chromatographic analysis of amphetamine derivatives and morpholine-related drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Benzphetamine; Chromatography, Gas; DOM 2,5-Dimethoxy-4-Methylamphetamine; Ephedrine; Forensic Medicine; Mescaline; Methamphetamine; Morpholines; Phentermine; Phenylpropanolamine | 1977 |
Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomers.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Behavior, Animal; Blood Pressure; Cats; Female; Hallucinogens; Isomerism; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Proadifen | 1978 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Brain; Drug Interactions; Drug Tolerance; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1992 |
Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Brain; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Indans; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Serotonin | 1991 |
Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Predictive Value of Tests; Reproducibility of Results | 1991 |
Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Brain; Cell Fractionation; Designer Drugs; Digitonin; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Synaptosomes; Thermodynamics | 1990 |
Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Columbidae; Discrimination, Psychological; Female; Fenfluramine; Generalization, Stimulus; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Chloride | 1990 |
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Fluoxetine; Gait; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Brain; Cerebral Cortex; Dopamine; Hippocampus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1990 |
A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Desipramine; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Oxidopamine; Psychotropic Drugs; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Septal Nuclei | 1989 |
MDMA produces stimulant-like conditioned locomotor activity.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1989 |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1989 |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Benzphetamine; Cytochrome P-450 Enzyme System; Kinetics; Male; Methamphetamine; Methimazole; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; NADP; Oxidoreductases, N-Demethylating; Rats; Spectrophotometry | 1986 |
The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Avoidance Learning; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Food; Macaca mulatta; Male; N-Methyl-3,4-methylenedioxyamphetamine | 1986 |
Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Columbidae; Discrimination Learning; Discrimination, Psychological; N-Methyl-3,4-methylenedioxyamphetamine | 1986 |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Biological Transport; Corpus Striatum; Depression, Chemical; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dopamine; Hippocampus; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes | 1987 |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Fluorescence Polarization; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic | 1988 |
Drug discrimination studies with MDMA and amphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1988 |
The clandestine drug laboratory situation in the United States.
Topics: 3,4-Methylenedioxyamphetamine; Acetone; Amphetamine; Drug and Narcotic Control; Humans; Illicit Drugs; Methamphetamine; Methaqualone; Pharmaceutical Preparations; Phencyclidine; Substance-Related Disorders; United States | 1983 |
MDA: a psychoactive agent with dual stimulus effects.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dextroamphetamine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Generalization, Stimulus; Male; Rats; Rats, Inbred Strains; Stereoisomerism | 1984 |
Further investigation of the discriminative stimulus properties of MDA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dextroamphetamine; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Isomerism; Male; Rats; Rats, Inbred Strains | 1984 |
Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 1995 |
Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Designer Drugs; Fluorides; Gas Chromatography-Mass Spectrometry; Methamphetamine; Microwaves; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine | 1994 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism | 1994 |
Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Treatment Centers; Substance-Related Disorders; Ultraviolet Rays | 1993 |
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Biogenic Monoamines; Brain; Calcium; Electric Stimulation; Female; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Pargyline; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Cross Reactions; Designer Drugs; Gas Chromatography-Mass Spectrometry; Immunoassay; Injections, Intravenous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Sensitivity and Specificity; Stereoisomerism | 1993 |
'Ecstasy' ingestion: a case report of severe complications.
Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Amphetamine; Designer Drugs; Disseminated Intravascular Coagulation; Humans; Liver; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rhabdomyolysis; Substance-Related Disorders | 1993 |
Ecstasy and Whizz at a rave resulting in a major burn plus complications.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Burns; Designer Drugs; Drug Overdose; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1993 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
"ADAM' or "EVE'?--a toxicological conundrum.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Female; Homicide; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine | 1996 |
Psychostimulant-like effects of p-fluoroamphetamine in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Behavior, Animal; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dronabinol; Expert Testimony; Gas Chromatography-Mass Spectrometry; Hair; Heroin Dependence; Humans; Illicit Drugs; Marijuana Abuse; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Psychotropic Drugs; Sensitivity and Specificity | 1996 |
Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Substance Abuse Detection | 1997 |
[Designer drugs in Jutland].
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Capsules; Denmark; Designer Drugs; Drug and Narcotic Control; Forensic Medicine; Humans; Specimen Handling; Tablets | 2001 |
Danger: possibly fatal interactions between ritonavir and "ecstasy," some other psychoactive drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Cocaine; Drug Interactions; Fatal Outcome; Hallucinogens; Heroin; HIV Protease Inhibitors; Humans; Illicit Drugs; Male; Methadone; Ritonavir | 1997 |
Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrum Analysis, Raman | 2001 |
Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Chromatography, High Pressure Liquid; Designer Drugs; Forensic Medicine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2002 |
Quantitation of amphetamine, methamphetamine, and their methylenedioxy derivatives in urine by solid-phase microextraction coupled with electrospray ionization-high-field asymmetric waveform ion mobility spectrometry-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Hallucinogens; Humans; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2002 |
Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Hallucinogens; Isomerism; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Reward; Social Isolation | 2002 |
Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ephedrine; Humans; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection | 2003 |
Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2003 |
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Canada; Cocaine; Dopamine Uptake Inhibitors; Drug Contamination; Female; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Illicit Drugs; Male; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine | 2004 |
Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Gas; Humans; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2006 |
Time-resolved hair analysis of MDMA enantiomers by GC/MS-NCI.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biomarkers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Gas Chromatography-Mass Spectrometry; Hair; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Time Factors | 2007 |
Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2008 |
Simultaneous derivatization and extraction of amphetamine and methylenedioxyamphetamine in urine with headspace liquid-phase microextraction followed by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Humans; Solvents; Urine | 2008 |
Elimination half-lives of benzoylecgonine and MDMA in an apprehended driver.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Automobile Driving; Cocaine; Forensic Toxicology; Half-Life; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2008 |
Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nails; Observer Variation; Reproducibility of Results; Substance Abuse Detection | 2008 |
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Cocaine; Dronabinol; Humans; Illicit Drugs; Ketamine; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors | 2009 |
The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Isoenzymes; Microsomes, Liver; Stereoisomerism; Substrate Specificity | 2009 |
Rapid and simple determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography-mass spectrometry using micro-pulverized extraction.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2010 |
Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Deuterium; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Dronabinol; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Methamphetamine; Phencyclidine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2010 |
Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Amphetamine; Animals; Calcium; Cholinergic Agents; Dose-Response Relationship, Drug; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; PC12 Cells; Piperazines; Potassium Chloride; Rats; Serotonin Receptor Agonists | 2012 |
Molecularly imprinted solid-phase extraction for the selective determination of methamphetamine, amphetamine, and methylenedioxyphenylalkylamine designer drugs in human whole blood by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Adsorption; Amphetamine; Amphetamines; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Molecular Imprinting; Polymers; Solid Phase Extraction | 2012 |
Quantitative Silylation Speciations of Primary Phenylalkyl Amines, Including Amphetamine and 3,4-Methylenedioxyamphetamine Prior to Their Analysis by GC/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Molecular Structure | 2015 |
Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biodegradation, Environmental; Kinetics; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photochemical Processes; Rivers; Sewage; Stereoisomerism; Wastewater; Water; Water Microbiology | 2016 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |
MDMA Intoxication in a Potential Organ Donor with Cardiac Arrest.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Amphetamine; Drug Overdose; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Heart Arrest; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tissue Donors | 2020 |
Qualitative Screening of Amphetamine- and Ketamine-Type Abuse Drugs in Urine Employing Dual Mode Extraction Column by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Ephedrine; Humans; Illicit Drugs; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Polymethyl Methacrylate; Pseudoephedrine; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2023 |
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Carrier Proteins; Dopamine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin | 2022 |
Identification and classification of ATS in oral fluid based on Ag nanoassemblies on Si surface doped with Au nanobipyramids.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Methamphetamine; Nitrogen Compounds; Reproducibility of Results | 2023 |
Differences among youthful users and nonusers of drugs based on their perceptions of parental behavior.
Topics: Adolescent; Amphetamine; Authoritarianism; Barbiturates; Cannabis; Ethnicity; Female; Hostility; Humans; Love; Lysergic Acid Diethylamide; Male; Parent-Child Relations; Parents; Rural Population; Sex Factors; Social Class; Social Perception; Substance-Related Disorders; Urban Population | 1974 |